(Q34337328)

1 August 2017

Important controversies associated with isotretinoin therapy for acne (English)

1 reference

1 August 2017

Stephen E Wolverton

1

1 reference

PubMed ID

23559397

1 August 2017

Julie C Harper

series ordinal

2

1 reference

1 August 2017

1 April 2013

1 reference

American Journal of Clinical Dermatology

1 August 2017

1 reference

1 August 2017

14

1 reference

1 August 2017

2

1 reference

1 August 2017

71-76

1 reference

https://scigraph.springernature.com/pub.10.1007/s40257-013-0014-z

1 August 2017

0 references

cites work

An analysis of reports of depression and suicide in patients treated with isotretinoin

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Isotretinoin use and subsequent depression and suicide: presenting the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Evaluation of depressive symptoms in acne patients treated with isotretinoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

The psychological and emotional impact of acne and the effect of treatment with isotretinoin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Isotretinoin and antidepressant pharmacotherapy: a prescription sequence symmetry analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

A causal association between isotretinoin and inflammatory bowel disease has yet to be established.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Possible Association Between Isotretinoin and Inflammatory Bowel Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Isotretinoin use and the risk of inflammatory bowel disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

The impact of the iPLEDGE program on isotretinoin fetal exposure in an integrated health care system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-013-0014-Z

10.1007/S40257-013-0014-Z

21 January 2018

Identifiers

DOI

1 reference

PubMed ID

23559397

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

23559397